Pluripotent Transcription Factors Possess Distinct Roles in Normal versus Transformed Human Stem Cells

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Ji, Junfeng ^a,b   Werbowetski Ogilvie, Tamra E ^a   Zhong, Bonan ^c   Hong, Seok Ho ^a   Bhatia, Mickie ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; FLOW CYTOMETRY; HUMAN; LENTIVIRINAE; METABOLISM; METHODOLOGY; PLURIPOTENT STEM CELL; TERATOMA;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TRANSFORMED; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; LENTIVIRUS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; TERATOMA; TRANSCRIPTION FACTORS;

EID: 77649275200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008065     Document Type: Article

References (44)

1. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al.(2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
3. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
4. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
5. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al.(2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
6. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al.(2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
7. Dick JE, (2008) Stem cell concepts renew cancer research. Blood 112: 4793-4807.
8. Rosen JM, Jordan CT, (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
9. Lessard J, Sauvageau G, (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260.
10. Boyer LA, Mathur D, Jaenisch R, (2006) Molecular control of pluripotency. Curr Opin Genet Dev 16: 455-462.
11. Niwa H, Miyazaki J, Smith AG, (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376.
12. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al.(2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
13. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al.(2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
14. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, et al.(2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
15. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, et al.(2009) Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005.
16. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al.(2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
17. Somervaille TC, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, et al.(2009) Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4: 129-140.
18. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, et al.(2008) Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2: 333-344.
19. Gidekel S, Pizov G, Bergman Y, Pikarsky E, (2003) Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4: 361-370.
20. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, et al.(2008) Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 68: 6281-6291.
21. Knoepfler PS, (2009) Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27: 1050-1056.
22. Hochedlinger K, Yamada Y, Beard C, Jaenisch R, (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477.
23. Hoei-Hansen CE, (2008) Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men. Cancer Treat Rev 34: 348-367.
24. Alldridge L, Metodieva G, Greenwood C, Al-Janabi K, Thwaites L, et al.(2008) Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J Proteome Res 7: 1458-1469.
25. Ezeh UI, Turek PJ, Reijo RA, Clark AT, (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265.
26. Ye F, Zhou C, Cheng Q, Shen J, Chen H, (2008) Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 8: 108.
27. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, et al.(2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095.
28. Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G, (2008) Identification of a tumor-initiating stem cell population in human renal carcinomas. Faseb J 22: 3696-3705.
29. Zhang S, Balch C, Chan MW, Lai HC, Matei D, et al.(2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320.
30. Werbowetski-Ogilvie TE, Bosse M, Stewart M, Schnerch A, Ramos-Mejia V, et al.(2009) Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 27: 91-97.
31. Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J, et al.(2005) High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23: 299-305.
32. Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, et al.(2004) Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22: 659-668.
33. Stewart MH, Bosse M, Chadwick K, Menendez P, Bendall SC, et al.(2006) Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods 3: 807-815.
34. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H, (2007) Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene 26: 5564-5576.
35. Chew JL, Loh YH, Zhang W, Chen X, Tam WL, et al.(2005) Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25: 6031-6046.
36. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, et al.(2005) Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280: 24731-24737.
37. Damjanov I, Andrews PW, (2007) The terminology of teratocarcinomas and teratomas. Nat Biotechnol 25: 1212; discussion 1212.
38. Lensch MW, Ince TA, (2007) The terminology of teratocarcinomas and teratomas. Nat Biotechnol 25: 1211; author reply 1211-1212.
39. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al.(2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
40. Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, et al.(2007) Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1: 403-415.
41. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, et al.(2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102: 906-915.
42. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, et al.(2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406.
43. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK, (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 90: 8033-8037.
44. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.